Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy
Saixian Shi, Ye Chen, Zhijian Luo, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Lin Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors
Mohamed S. Dabour, Mina Y. George, Mary R. Daniel, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 159-182
Open Access | Times Cited: 15
Inflammation, oxidative stress and mitochondrial dysfunction in the progression of type II diabetes mellitus with coexisting hypertension
Hibba Yousef, Ahsan H. Khandoker, Samuel F. Feng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 23
Tumor-targeted and stimulus-responsive polymeric prodrug nanoparticles to enhance the anticancer therapeutic efficacy of doxorubicin
Nuri Kim, Soonyoung Kwon, Gayoung Kwon, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 351-362
Closed Access | Times Cited: 9
Role of Oxidative Stress and Inflammation in Doxorubicin-Induced Cardiotoxicity: A Brief Account
Roberta Vitale, Stefania Marzocco, Ada Popolo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7477-7477
Open Access | Times Cited: 9
DOXORUBICIN-RELATED CARDIOTOXICITY: REVIEW OF FUNDAMENTAL PATHWAYS OF CARDIOVASCULAR SYSTEM INJURY
Ashot Avagimyan, Nana Pogosova, L. V. Kakturskiy, et al.
Cardiovascular Pathology (2024) Vol. 73, pp. 107683-107683
Closed Access | Times Cited: 9
A Comprehensive Overview on Chemotherapy-Induced Cardiotoxicity: Insights into the Underlying Inflammatory and Oxidative Mechanisms
András Nagy, Denise Börzsei, Alexandra Hoffmann, et al.
Cardiovascular Drugs and Therapy (2024)
Open Access | Times Cited: 8
SIRT1 signaling pathways in sarcopenia: Novel mechanisms and potential therapeutic targets
Luning Yang, Di Liu, Shide Jiang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116917-116917
Open Access | Times Cited: 8
Doxorubicin-Induced Cardiac Remodeling: Mechanisms and Mitigation Strategies
Yingpu Sun, Lili Xiao, Linlin Chen, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access
Toll-like Receptor 4 Inflammatory Perspective on Doxorubicin-Induced Cardiotoxicity
Natticha Sumneang, Pongpan Tanajak, Thura Tun Oo
Molecules (2023) Vol. 28, Iss. 11, pp. 4294-4294
Open Access | Times Cited: 19
Irisin protects against doxorubicin-induced cardiotoxicity by improving AMPK-Nrf2 dependent mitochondrial fusion and strengthening endogenous anti-oxidant defense mechanisms
Caili Zhuo, Juan-Juan Xin, Wenjing Huang, et al.
Toxicology (2023) Vol. 494, pp. 153597-153597
Closed Access | Times Cited: 16
Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity
Thais Peclat, Guillermo Agorrody, Laura Colman, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 3, pp. 286-300
Open Access | Times Cited: 5
NOX4 aggravates doxorubicin-induced cardiomyocyte pyroptosis by increasing reactive oxygen species content and activating the NLRP3 inflammasome
Hong Zeng, Pengtao Zou, Yanmei Chen, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 1, pp. 84-100
Open Access | Times Cited: 5
The mechanism and therapeutic strategies in Doxorubicin induced cardiotoxicity: Role of programmed cell death
Yanzhao Li, Jing Yan, Pingzhen Yang
Cell Stress and Chaperones (2024)
Open Access | Times Cited: 5
PLGA Polymers and Doxorubicin for the Treatment of Malignant Gliomas in Adults: An Overview
V. V. Kudelkina, Andrey D. Gerasimov, А. М. Косырева, et al.
The Open Medicinal Chemistry Journal (2025) Vol. 19, Iss. 1
Open Access
Aprocitentan mitigates doxorubicin-induced cardiotoxicity by inhibiting cuproptosis, oxidative stress, and mitochondrial impairments via the activation of sirtuin 7
Yufei Chen, Rui-Qiang Qi, Zhao Lin, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114141-114141
Closed Access
Effectively alleviate rheumatoid arthritis via maintaining redox balance, inducing macrophage repolarization and restoring homeostasis of fibroblast-like synoviocytes by metformin-derived carbon dots
Rui Zhang, Xingyu Lin, Rongjie Lin, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Managing Doxorubicin Cardiotoxicity: Insights Into Molecular Mechanisms and Protective Strategies
Adnan Taan Al khafaji, Ali Barakat, Akram Joudah shayyal, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access
Small extracellular vesicles derived from Nrf2-stimulated bone marrow mesenchymal stem cells ameliorated the testis damage and fertility disorder in doxorubicin-treated mice
M. A. Taher, Hanieh Jalali, Homa Mohseni Kouchesfahani
Reproductive Toxicology (2025) Vol. 132, pp. 108847-108847
Closed Access
Hollow mesoporous prussian blue nanozymes alleviate doxorubicin-induced cardiotoxicity by restraining oxidative stress associated with Nrf2 signaling
Fang Wang, Ke Wang, Baoru Fang, et al.
Journal of Colloid and Interface Science (2025) Vol. 686, pp. 1074-1088
Closed Access
Irisin Mitigates Doxorubicin-Induced Cardiotoxicity by Reducing Oxidative Stress and Inflammation via Modulation of the PERK-eIF2α-ATF4 Pathway
Zilong Zhang, Xiaolin Yu, Jie Li, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1067-1081
Open Access
Nanoscale strategies: doxorubicin resistance challenges and enhancing cancer therapy with advanced nanotechnological approaches
Jian Xin Lim, Yoke Keong Yong, Firli Rahmah Primula Dewi, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Downregulated TRIM35 Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress and Inflammation via Inhibiting TLR4/NF-κB Pathway
Yewen Hu, Shiqi Wang, Chaoxia Zhang, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access
Human umbilical cord mesenchymal stem cell-derived exosome ameliorate doxorubicin-induced senescence
Zhen Yang, Yan Feng, Jiangwei Yuan, et al.
Experimental Cell Research (2025), pp. 114450-114450
Closed Access
Low‐Power Blue LED Modulates NF‐κB and Proinflammatory Cytokines in Doxorubicin‐Treated MDA‐MB‐231 Cells
Adilson Fonseca Teixeira, Bruno Ricardo Barreto Pires, Carolina Panis, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Open Access
Page 1 - Next Page

Scroll to top